D. Hosking

1.1k total citations
10 papers, 734 citations indexed

About

D. Hosking is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, D. Hosking has authored 10 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Orthopedics and Sports Medicine and 3 papers in Molecular Biology. Recurrent topics in D. Hosking's work include Bone health and treatments (9 papers), Bone and Joint Diseases (5 papers) and Bone health and osteoporosis research (4 papers). D. Hosking is often cited by papers focused on Bone health and treatments (9 papers), Bone and Joint Diseases (5 papers) and Bone health and osteoporosis research (4 papers). D. Hosking collaborates with scholars based in United Kingdom, United States and Canada. D. Hosking's co-authors include G. David Roodman, Yasuyoshi Ohsaki, Frederick R. Singer, Akiko Kukita, Noriyoshi Kurihara, Giovanni Cizza, J.F. Smith, Michael R. McClung, Anne Demulder and Desmond Thompson and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Bone and Mineral Research.

In The Last Decade

D. Hosking

10 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Hosking United Kingdom	5	344	311	240	132	105	10	734
S.H. Ralston United Kingdom	18	490 1.4×	350 1.1×	371 1.5×	163 1.2×	105 1.0×	35	1.0k
Stefan Kudlacek Austria	20	411 1.2×	320 1.0×	417 1.7×	113 0.9×	62 0.6×	49	1.0k
W.R. Holloway Australia	8	228 0.7×	237 0.8×	407 1.7×	106 0.8×	95 0.9×	9	758
J. Dequeker Belgium	10	387 1.1×	136 0.4×	171 0.7×	56 0.4×	141 1.3×	11	663
Elizabeth C. Wahl United States	15	278 0.8×	194 0.6×	407 1.7×	70 0.5×	54 0.5×	22	763
Lynn Kohlmeier United States	11	306 0.9×	181 0.6×	187 0.8×	77 0.6×	47 0.4×	13	703
Qiuju Huang Netherlands	7	414 1.2×	175 0.6×	289 1.2×	65 0.5×	180 1.7×	9	794
C. Moniz United Kingdom	13	148 0.4×	224 0.7×	202 0.8×	38 0.3×	236 2.2×	17	651
Paula Dakin United States	9	613 1.8×	561 1.8×	378 1.6×	70 0.5×	165 1.6×	34	970
Gabriel M. Pagnotti United States	15	265 0.8×	233 0.7×	374 1.6×	238 1.8×	36 0.3×	29	939

Countries citing papers authored by D. Hosking

Since Specialization

Citations

This map shows the geographic impact of D. Hosking's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Hosking with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Hosking more than expected).

Fields of papers citing papers by D. Hosking

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Hosking. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Hosking. The network helps show where D. Hosking may publish in the future.

Co-authorship network of co-authors of D. Hosking

This figure shows the co-authorship network connecting the top 25 collaborators of D. Hosking. A scholar is included among the top collaborators of D. Hosking based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Hosking. D. Hosking is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Reid, Ian R., Kenneth W. Lyles, Grace L. Su, et al.. (2010). Long-term efficacy of zoledronic acid compared with risedronate in Paget's disease. Bone. 47. S38–S38. 4 indexed citations

Hosking, D., S. Adámi, Dieter Felsenberg, et al.. (2003). Once weekly alendronate produces a greater increase in bone mineral density than daily risedronate. Open Repository and Bibliography (University of Liège). 1 indexed citations

Hosking, D., S. Adámi, Dieter Felsenberg, et al.. (2002). Once weekly alendronate produces a greater decrease in bone resorption than does daily risedronate. Open Repository and Bibliography (University of Liège). 1 indexed citations

Ilnyckyj, Alexandra, D. Hosking, Norman M. Pettigrew, & Çharles N. Bernstein. (1999). Case Report: Extracorporeal Shock Wave Lithotripsy Causing Colonic Injury. Digestive Diseases and Sciences. 44(12). 2485–2487. 13 indexed citations

Ravn, Pernille, Giovanni Cizza, N. H. Bjarnason, et al.. (1999). Low Body Mass Index Is an Important Risk Factor for Low Bone Mass and Increased Bone Loss in Early Postmenopausal Women. Journal of Bone and Mineral Research. 14(9). 1622–1627. 367 indexed citations

Roodman, G. David, Yasuyoshi Ohsaki, Myrna M. Miller, et al.. (1998). Pagetic osteoclasts formed in vitro: absence of paracrystalline inclusions.. PubMed. 30(2). 315–27. 2 indexed citations

Griffith, K., Derek Pearson, & D. Hosking. (1996). 7. Development of a bone scintigraphy whole-body index to monitor the response to bisphosphonate therapy in Pagetʼs disease. Nuclear Medicine Communications. 17(11). 987–987. 1 indexed citations

Harris, Steven T., D. Hosking, S. Adámi, et al.. (1996). Treatment with alendronate prevents fractures in women with postmenopausal osteoporosis. Osteoporosis International. 6(S1). 261–261. 1 indexed citations

Roodman, G. David, Noriyoshi Kurihara, Yasuyoshi Ohsaki, et al.. (1992). Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone.. Journal of Clinical Investigation. 89(1). 46–52. 299 indexed citations

10.

Hosking, D., et al.. (1976). PAGET'S BONE DISEASE TREATED WITH DIPHOSPHONATE AND CALCITONIN. The Lancet. 307(7960). 615–617. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact